The brand's dedication to science and transparency has
quickly made MDbio the leading clinically proven nutraceutical
brand in America.
LOS
ANGELES, July 31, 2024 /PRNewswire/ -- Founded by
four accomplished board-certified physicians, MDbio - The Doctors
Brand™ has achieved the distinction of becoming the leading
clinically studied supplement brand in the U.S. for sleep, mood,
and pain relief, based on rigorous gold standard clinical trials
involving over 3,500 diverse Americans. This remarkable clinical
trial record sets a new standard, with few supplement brands
reaching this level of clinical validation.
Finally physicians and consumers have
natural clinically proven solutions for pain, sleep and anxiety.
Kiarash Michel, MD
MDbio's commitment exceeds regulatory requirements for
supplements, aligning more closely with pharmaceutical standards.
This blend of best practices has enabled MDbio to deliver safe and
effective solutions for both practitioners and their patients.
MDrelief and MDcalm join MDsleep's clinically studied status in
what are some of the largest clinical trials in supplement
history.
Clinical trial findings include:
- MDcalm: Significantly outperformed placebo for anxiety and
sleep disturbance, leading to clinically meaningful improvements in
77% and 66% of participants, respectively, in clinical trials
involving 1,461 U.S. adults.
- MDsleep: Significantly outperformed placebo for sleep
disturbance, anxiety, and stress, leading to clinically meaningful
improvements in 57%, 60%, and 38% of participants, respectively, in
clinical trials involving 620 U.S. adults. MDsleep also
significantly outperformed placebo for improved quality of
life.
- MDrelief: Significantly outperformed placebo for pain
interference and pain intensity in women below age 50 (the
approximate average age of menopause). Averaged across all genders
and ages (21 to 77), clinically meaningful improvements were seen
in pain interference and pain intensity in 54% and 66% of
participants respectively, in clinical trials involving 1,160 U.S.
adults.
All studies were double-blinded, randomized, placebo-controlled
clinical trials conducted by Radicle Science, a public benefit
corporation powering the future of Personalized Wellness with
clinical proof. The Radicle Science research team is led by
scientists and physicians in collaboration with faculty from
UCLA, UC San Diego. Johns Hopkins, Harvard, University of Maryland, and more.
Jeff Chen, MD, Co-founder and CEO
of Radicle Science, stated, "MDbio represents the future of
evidence backed natural products that are proven to deliver
benefits, earning the trust of consumers, retailers, and doctors
alike."
MDbio was founded by four renowned Los
Angeles physicians—Kiarash
Michel, MD; Babak Larian, MD,
FACS; Siamak Tabib, MD; and
Kamran Jamshidinia, DPM, FACFAS—.
Over ten years ago, they noticed patients with chronic conditions
faced significant side effects from existing pharmaceutical
treatments and had no scientifically-backed alternatives. This
glaring consumer need led the doctors to found MDbio to offer
clinically proven natural alternatives.
"Now consumers finally have natural clinically proven solutions
for some of the body's most prevalent destabilizers. These include
pain, sleep, and anxiety which are also often intertwined and
difficult to treat in isolation," states Kiarash Michel, MD. "Physicians and clinicians
now have a product line they can trust since clinical research is
the only barometer that proves efficacy."
It's estimated that less than 1% of supplement brands have a
single clinically proven product, and virtually no supplement brand
has multiple proven products. Most brands resort to using an
unproven formulation, which are often generic and used by other
brands as well. These formulations might include an ingredient that
underwent clinically low-quality studies involving a small number
of participants, often in foreign countries like India and China (which have been called out as hotbeds
for fake medical research). However, relying exclusively on a
potentially effective ingredient isn't enough. Virtually no
supplement brands can demonstrate whether their entire product is
truly effective or is merely a placebo, especially for diverse
Americans with distinct genetic, lifestyle, and environmental
factors.
MDbio recognizes why it's critical to develop and test complete
formulations with the synergy of all ingredients in mind. This
poly-pharmacological approach studies any contraindications and
helps maintain the mild side effect profile seen in MDbio's
products that work with the body to reach homeostasis. It's
only after rigorous in-house studies detect high effectiveness and
a safe side effect profile does MDbio proceed with clinical trials
and ultimately launch products into the market.
Key Elements of MDbio's Success:
- Extensive Preclinical Research: MDbio's formulations are
based on rigorous preclinical research, ensuring a strong
scientific foundation.
- Large-Scale Clinical Trials: MDbio conducts extensive
third-party double-blind, randomized, placebo-controlled clinical
trials. The trials for MDsleep, MDcalm and MDrelief, involved over
3,000 diverse Americans to confirm the efficacy and safety of these
products.
- Real-World Data Surveillance: MDbio continuously monitors
real-world outcomes from patients using their products, allowing
ongoing assessment and optimization.
Consumers are increasingly prioritizing "proof of efficacy and
scientific credibility" when selecting non-prescription wellness
products, according to a 2024 McKinsey Future of Wellness report
which surveyed 5,000 consumers. With 82% of U.S. consumers making
wellness a daily priority and 65% trusting physicians for health
advice, healthcare providers seek scientifically-backed
non-pharmaceutical products to recommend confidently. Most wellness
brands rely on marketing tactics, misleading labels and unverified
claims.
MDbio bridges the gap between pharmaceutical science and
nutraceutical safety, providing consumers with products that are
both effective and have minimal side effects.
The results of the MDsleep clinical trial was published in the
peer-reviewed journal, Nutrients, underscoring the credibility of
MDbio's offerings, and more peer-reviewed publications are underway
for MDbio's newest products and studies.
Their commitment to a scientific approach to validate
formulations introduces a new standard for the supplement industry
where consumers will no longer have to choose between harsh
pharmaceutical side effects and unproven natural health
products.
About MDbio - The Doctors Brand™
MDbio - The Doctors Brand™ is committed to patient safety and
health outcomes, using a scientific and evidence-based approach to
product development, clinical validation, and real-world data
monitoring. With a track record of rigorous clinical trials and
studies involving over 3,500 diverse Americans, MDbio has become
the leading supplement brand in the U.S. for sleep, mood, and pain.
U.S. patients now have access to non-prescription products that are
safe, affordable, and effective for improving their overall
wellness. To learn more, please visit www.mdbiowellness.com.
For more information about MDbio - The Doctors Brand™ and its
products, please visit www.mdbiowellness.com.
Media contact:
Ray Drasnin
Director of Communications, MDbio - The Doctors Brand™
Phone: (619)890-6000
Email: press@mdbiowellness.com
This press release is available online at HERE. For additional
information, follow us on LinkedIn, Instagram, Facebook, and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/mdbio---the-doctors-brand---delivers-proof-driven-wellness-products-exceeding-consumer-expectations-302210605.html
SOURCE MDbio - The Doctors Brand